Related Experiment Video
Updated: Dec 25, 2025

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
TMEM16A ameliorates vascular remodeling by suppressing autophagy via inhibiting Bcl-2-p62 complex formation
Xiao-Fei Lv1, Ya-Juan Zhang1, Xiu Liu1
1Department of Pharmacology and Cardiac & Cerebral Vascular Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Abstract:
Rationale: Transmembrane member 16A (TMEM16A) is a component of calcium-activated chloride channels that regulate vascular smooth muscle cell (SMC) proliferation and remodeling. Autophagy, a highly conserved cellular catabolic process in eukaryotes, exerts important physiological functions in vascular SMCs. In the current study, we investigated the relationship between TMEM16A and autophagy during vascular remodeling. Methods: We generated a transgenic mouse that overexpresses TMEM16A specifically in vascular SMCs to verify the role of TMEM16A in vascular remodeling. Techniques employed included immunofluorescence, electron microscopy, co-immunoprecipitation, and Western blotting. Results: Autophagy was activated in aortas from angiotensin II (AngII)-induced hypertensive mice with decreased TMEM16A expression. The numbers of light chain 3B (LC3B)-positive puncta in aortas correlated with the medial cross-sectional aorta areas and TMEM16A expression during hypertension. SMC-specific TMEM16A overexpression markedly inhibited AngII-induced autophagy in mouse aortas. Moreover, in mouse aortic SMCs (MASMCs), AngII-induced autophagosome formation and autophagic flux were blocked by TMEM16A upregulation and were promoted by TMEM16A knockdown. The effect of TMEM16A on autophagy was independent of the mTOR pathway, but was associated with reduced kinase activity of the vacuolar protein sorting 34 (VPS34) enzyme. Overexpression of VPS34 attenuated the effect of TMEM16A overexpression on MASMC proliferation, while the effect of TMEM16A downregulation was abrogated by a VPS34 inhibitor. Further, co-immunoprecipitation assays revealed that TMEM16A interacts with p62. TMEM16A overexpression inhibited AngII-induced p62-Bcl-2 binding and enhanced Bcl-2-Beclin-1 interactions, leading to suppression of Beclin-1/VPS34 complex formation. However, TMEM16A downregulation showed the opposite effects. Conclusion: TMEM16A regulates the four-way interaction between p62, Bcl-2, Beclin-1, and VPS34, and coordinately prevents vascular autophagy and remodeling.
Insights
Transmembrane member 16A (TMEM16A) prevents vascular autophagy and remodeling by regulating interactions between p62, Bcl-2, Beclin-1, and VPS34. TMEM16A overexpression inhibits autophagy, while its downregulation promotes it, impacting vascular smooth muscle cell proliferation.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Molecular Medicine
Background:
- Transmembrane member 16A (TMEM16A) is implicated in vascular smooth muscle cell (SMC) proliferation and remodeling.
- Autophagy plays crucial roles in vascular SMC physiology.
- The interplay between TMEM16A and autophagy in vascular remodeling requires elucidation.
Purpose of the Study:
- To investigate the relationship between TMEM16A and autophagy in the context of vascular remodeling.
- To determine the molecular mechanisms by which TMEM16A influences autophagy and SMC behavior.
Main Methods:
- Generation of a TMEM16A-overexpressing transgenic mouse model specifically in vascular SMCs.
- Utilized immunofluorescence, electron microscopy, co-immunoprecipitation, and Western blotting.
- Assessed autophagy markers (LC3B), autophagic flux, and protein-protein interactions in response to angiotensin II (AngII) stimulation.
Main Results:
- Hypertension-induced aortic remodeling correlated with decreased TMEM16A expression and activated autophagy.
- TMEM16A overexpression inhibited AngII-induced autophagy and SMC proliferation in mouse aortas and isolated SMCs.
- TMEM16A regulated autophagy independently of mTOR but via modulation of vacuolar protein sorting 34 (VPS34) kinase activity and interaction with p62, Bcl-2, and Beclin-1.
Conclusions:
- TMEM16A acts as a critical regulator of vascular autophagy and remodeling.
- TMEM16A controls a molecular complex involving p62, Bcl-2, Beclin-1, and VPS34.
- Modulating TMEM16A activity offers a potential therapeutic strategy for vascular remodeling-related diseases.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
The Tumor Microenvironment

